Home
Stocks Trading
Analyst Snapshot
Financial Scores
Market Summary

Halozyme Therapeutics Inc (NASDAQ: HALO)

HALO’s price-to-free cash flow ratio: How it affects investment decisions

December 19, 2025

Cameron Mitchell

Currently, Halozyme Therapeutics Inc’s (HALO) stock is trading at $66.11, marking a gain of 1.54% from last night’s close. At ...

Most Recent

Stocks Trading

UroGen Pharma Ltd (URGN) stock analysis: A simple moving average approach

Market Summary

Vir Biotechnology Inc (VIR)’s highs and lows: A closer look at its stock price fluctuations

Financial Scores

A year in review: 4D Molecular Therapeutics Inc (FDMT)’s performance in the last year

Analyst Snapshot

CGTX underperforms with a -2.05 decrease in share price

Stocks Trading

Technical analysis of Northern Dynasty Minerals Ltd (NAK) stock chart patterns

Market Summary

InflaRx N.V (IFRX) stock shows negative growth on Friday

Who We Are

Fueled by a passion for truth since 1992, US Post News brings you trustworthy journalism. Our team of investigators, photographers, and writers delivers fresh news you can rely on. We started with ink and screens, but today we’re a web leader, illuminating the world with verified information.

Company

About US
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled